Boston Children’s Hospital-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Boston Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012302
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boston Children’s Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children’s is headquartered in Boston, Massachusetts, the US.

Boston Children’s Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Boston Children’s Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Boston Children’s Hospital, Medical Devices Deals, 2011 to YTD 2017 10
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Amgen Enters into Research Agreement with Boston Children’s Hospital 13
Boston Children’s Hospital Enters into Agreement with GE Healthcare 14
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 15
Gruenenthal, Proteus and Boston Children’s Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children’s Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children’s Hospital 19
Boston Children’s Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children’s Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children’s Hospital 22
Children’s Hospital Boston Enters Into Research Agreement With Pfizer 23
Merger 24
Warren Hospital Merges With St. Luke’s Hospital 24
Licensing Agreements 25
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 25
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 26
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 27
Boston Children’s Hospital – Key Competitors 28
Boston Children’s Hospital – Key Employees 29
Boston Children’s Hospital – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 35
Recent Developments 36
Government and Public Interest 36
Dec 06, 2017: Routing gene therapy directly into the brain 36
Nov 07, 2017: Boston Children’s Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 38
Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 39
Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 40
May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 42
Mar 23, 2017: Effective one-shot vaccination of newborns moves closer to reality 44
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 46
Sep 14, 2016: Discovery Offers Prospect of Shorter Treatment and Cure for Chronic Myelogenous Leukemia 47
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 48
Jul 06, 2016: A new angle for countering severe bacterial infections and sepsis 50
Jun 06, 2016: New approach could make bone marrow transplants safer 51
Jan 25, 2016: Researchers Show Novel Material Encapsulated Human Islet Cells Can Halt Type 1 Diabetes for Six Months 52
Jan 19, 2016: Immune 1-2-3 punch against parasites reveals potentially ancient cell death pathway 53
Product News 54
Sep 14, 2016: Antibiotic gel squirted into the ear could provide a one-dose cure for ear infections 54
Jan 11, 2016: Immune punch against parasites reveals potentially ancient cell death pathway 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Boston Children's Hospital, Deals By Therapy Area, 2011 to YTD 2017 9
Boston Children's Hospital, Medical Devices Deals, 2011 to YTD 2017 10
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Amgen Enters into Research Agreement with Boston Children's Hospital 13
Boston Children's Hospital Enters into Agreement with GE Healthcare 14
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 15
Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 19
Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 22
Children's Hospital Boston Enters Into Research Agreement With Pfizer 23
Warren Hospital Merges With St. Luke's Hospital 24
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 25
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 26
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 27
Boston Children's Hospital, Key Competitors 28
Boston Children's Hospital, Key Employees 29
Boston Children's Hospital, Key Employees (cont..) 32
Boston Children's Hospital, Other Locations 34
Boston Children's Hospital, Subsidiaries 34
Boston Children's Hospital, Joint Venture 35

★海外企業調査レポート[Boston Children’s Hospital-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catalyst Biosciences Inc:企業のM&A・事業提携・投資動向
    Catalyst Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalyst Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gilead Sciences, Inc.:企業の戦略・SWOT・財務情報
    Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report Summary Gilead Sciences, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Core Laboratories NV (CLB):企業の財務・戦略的SWOT分析
    Core Laboratories NV (CLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • PharmaLundensis AB:医療機器:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Austin Industries Inc:企業の戦略・SWOT・財務分析
    Austin Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Austin Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Agile Therapeutics Inc (AGRX):企業の財務・戦略的SWOT分析
    Summary Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its p …
  • Columbia Sportswear Company (COLM):企業の財務・戦略的SWOT分析
    Columbia Sportswear Company (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PT Indo Tambangraya Megah Tbk:企業の戦略・SWOT・財務情報
    PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioGaia AB (BIOG B)-製薬・医療分野:企業M&A・提携分析
    Summary BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), str …
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Sonoma Orthopedic Products Inc-医療機器分野:企業M&A・提携分析
    Summary Sonoma Orthopedic Products Inc (Sonoma) is a medical device company that offers orthopedic products. The company provides long bone fixation system that reduces fixation time and patient discomfort. Its product include ankle pin, collarbone pin and wrist pin. Sonoma provides treatment for wr …
  • Lavendon Group Plc:企業の戦略・SWOT・財務情報
    Lavendon Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lavendon Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Power Grid Corporation of India Ltd (POWERGRID EQ):企業の財務・戦略的SWOT分析
    Power Grid Corporation of India Ltd (POWERGRID EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Genovis AB (GENO):製薬・医療:M&Aディール及び事業提携情報
    Summary Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company’s products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal ant …
  • Editas Medicine Inc (EDIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Editas Medicine Inc (Editas Medicine) formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its in-licensed clustered regularly interspaced short palin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆